Paper23318809
Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.
Rodgers W and 2 others. Antimicrob Agents Chemother, 2013. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae. Papers, record 23318809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23318809
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Haemophilus influenzae | Major topic |
| Macrolides | Major topic |
| Ribosomes | Major topic |
| Staphylococcus aureus | Major topic |
| Streptococcus pneumoniae | Major topic |
| Triazoles | Major topic |
| Anti-Infective Agents | |
| Inhibitory Concentration 50 | |
| Protein Biosynthesis |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11270656 | Structure-activity relationships for six ketolide antibiotics. | Curr Microbiol | 2001 | https://conductscience.org/library/papers/11270656 | PubMed |
| 2 | 12177734 | The ketolide antibiotic ABT-773 is a specific inhibitor of translation and 50S ribosomal subunit formation in Streptococcus pneumoniae cells. | Curr Microbiol | 2002 | https://conductscience.org/library/papers/12177734 | PubMed |
| 3 | 17562806 | Retapamulin inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17562806 | PubMed |
| 4 | 20176910 | CEM-101 activity against Gram-positive organisms. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20176910 | PubMed |
| 5 | 20831882 | The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009). | J Infect | 2010 | https://conductscience.org/library/papers/20831882 | PubMed |
| 6 | 12520364 | Preferential inhibition of protein synthesis by ketolide antibiotics in Haemophilus influenzae cells. | Curr Microbiol | 2003 | https://conductscience.org/library/papers/12520364 | PubMed |
| 7 | 19884376 | In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/19884376 | PubMed |
| 8 | 17168803 | The other target for ribosomal antibiotics: inhibition of bacterial ribosomal subunit formation. | Infect Disord Drug Targets | 2006 | https://conductscience.org/library/papers/17168803 | PubMed |
| 9 | 16096836 | Accumulation and turnover of 23S ribosomal RNA in azithromycin-inhibited ribonuclease mutant strains of Escherichia coli. | Arch Microbiol | 2005 | https://conductscience.org/library/papers/16096836 | PubMed |
| 10 | 19564365 | Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19564365 | PubMed |
| 11 | 10940010 | RNase III processing of intervening sequences found in helix 9 of 23S rRNA in the alpha subclass of Proteobacteria. | J Bacteriol | 2000 | https://conductscience.org/library/papers/10940010 | PubMed |
| 12 | 10216268 | Fragmentation heterogeneity of 23S ribosomal RNA in Haemophilus species. | Gene | 1999 | https://conductscience.org/library/papers/10216268 | PubMed |
| 13 | 22191530 | Antibiotics in development targeting protein synthesis. | Ann N Y Acad Sci | 2011 | https://conductscience.org/library/papers/22191530 | PubMed |
| 14 | 21862408 | Resistance drives antibacterial drug development. | Curr Opin Pharmacol | 2011 | https://conductscience.org/library/papers/21862408 | PubMed |
| 15 | 11544246 | Intervening sequences in rrl genes and fragmentation of 23S rRNA in genera of the family Enterobacteriaceae. | J Bacteriol | 2001 | https://conductscience.org/library/papers/11544246 | PubMed |
| 16 | 10648538 | Fragmentation of 23S rRNA in strains of Proteus and Providencia results from intervening sequences in the rrn (rRNA) genes. | J Bacteriol | 2000 | https://conductscience.org/library/papers/10648538 | PubMed |
| 17 | 20211548 | Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates. | Int J Antimicrob Agents | 2010 | https://conductscience.org/library/papers/20211548 | PubMed |
| 18 | 20022192 | CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria. | Diagn Microbiol Infect Dis | 2010 | https://conductscience.org/library/papers/20022192 | PubMed |
| 19 | 12232662 | Telithromycin inhibition of protein synthesis and 50S ribosomal subunit formation in Streptococcus pneumoniae cells. | Curr Microbiol | 2002 | https://conductscience.org/library/papers/12232662 | PubMed |
| 20 | 20855725 | Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20855725 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40212381 | Exploring the repurposed role of solithromycin as an antivirulence agent against Staphylococcus aureus and its resistant variants. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40212381 | PubMed |
| 38554170 | Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement. | Mol Divers | 2024 | https://conductscience.org/library/papers/38554170 | PubMed |
| 34546703 | Development of Genetically Encoded Biosensors for Reporting the Methyltransferase-Dependent Biosynthesis of Semisynthetic Macrolide Antibiotics. | ACS Synth Biol | 2021 | https://conductscience.org/library/papers/34546703 | PubMed |
| 32119845 | The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae. | Transl Res | 2020 | https://conductscience.org/library/papers/32119845 | PubMed |
| 31942624 | Antibiotics targeting bacterial ribosomal subunit biogenesis. | J Antimicrob Chemother | 2020 | https://conductscience.org/library/papers/31942624 | PubMed |
| 29891609 | Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and Adolescents. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29891609 | PubMed |
| 29678883 | Ribosome maturation by the endoribonuclease YbeY stabilizes a type 3 secretion system transcript required for virulence of enterohemorrhagic Escherichia coli. | J Biol Chem | 2018 | https://conductscience.org/library/papers/29678883 | PubMed |
| 29263651 | Spotlight on solithromycin in the treatment of community-acquired bacterial pneumonia: design, development, and potential place in therapy. | Drug Des Devel Ther | 2017 | https://conductscience.org/library/papers/29263651 | PubMed |
| 29068158 | Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid. | CPT Pharmacometrics Syst Pharmacol | 2017 | https://conductscience.org/library/papers/29068158 | PubMed |
| 28971877 | In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28971877 | PubMed |
| 27974410 | The Human Ureaplasma Species as Causative Agents of Chorioamnionitis. | Clin Microbiol Rev | 2017 | https://conductscience.org/library/papers/27974410 | PubMed |
| 27909995 | Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia. | Drugs | 2016 | https://conductscience.org/library/papers/27909995 | PubMed |
| 27401563 | Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27401563 | PubMed |
| 27353164 | Antibiotics in the clinical pipeline at the end of 2015. | J Antibiot (Tokyo) | 2017 | https://conductscience.org/library/papers/27353164 | PubMed |
| 27066004 | A New, Potent, and Placenta-Permeable Macrolide Antibiotic, Solithromycin, for the Prevention and Treatment of Bacterial Infections in Pregnancy. | Front Immunol | 2016 | https://conductscience.org/library/papers/27066004 | PubMed |
| 27044551 | Results from the Solithromycin International Surveillance Program (2014). | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27044551 | PubMed |
| 24236721 | Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review. | Curr Top Med Chem | 2014 | https://conductscience.org/library/papers/24236721 | PubMed |
| 24189250 | Maternal administration of solithromycin, a new, potent, broad-spectrum fluoroketolide antibiotic, achieves fetal and intra-amniotic antimicrobial protection in a pregnant sheep model. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24189250 | PubMed |
| 24092856 | Investigational antimicrobial agents of 2013. | Clin Microbiol Rev | 2013 | https://conductscience.org/library/papers/24092856 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23318809
GET https://conductscience.org/api/papers/v1/23318809/references?page=2